"SID26752069"@en . . . . "Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow."@en . . . . . . "Mitsuji Akazawa, Teruo Hama, Yukio Kimura, Yoshinobu Yasuda, \"Procaterol-containing preparation for application to the skin.\" U.S. Patent US5480649, issued February, 1989."@en . "Symptoms of overdose include angina (chest pain), dizziness, dry mouth, fatigue, flu-like symptoms, headache, heart irregularities, high or low blood pressure, high blood sugar, insomnia, muscle cramps, nausea, nervousness, rapid heartbeat, seizures, and tremor."@en . . . "SID11113915"@en . "Procaterol"@en . . . . . . "Because of the small therapeutic dose, systemic levels of salmeterol are low or undetectable after inhalation of recommended doses."@en . . . . . . . . "Humans and other mammals"@en . . . "approved"@en . "A long-acting beta-2-adrenergic receptor agonist. It is a potent bronchodilator that may be administered orally or by aerosol inhalation. [PubChem]"@en . . "For the treatment of asthma and chronic obstructive pulmonary disease (COPD)."@en . . . . . "72332-33-3"@en . . . . . . . . .